✦ LIBER ✦

Factors Which Impact Readmission in Those With Inflammatory Bowel Disease (IBD); A Retrospective Case Series

✍ Scribed by Nyla Hazratjee; Rocio Lopez; Maged K. Rizk

Book ID: 119432112
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 186 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60264-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors Which Impact Readmission in Thos

Factors Which Impact Readmission in Those With Liver Disease; A Retrospective Case Series

✍ Kochhar, Gursimran S. ;Phull, Hardeep ;Lopez, Rocio ;Rizk, Maged K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Tu1287 Factors Associated With 30-Day Re

Tu1287 Factors Associated With 30-Day Readmissions in Patients With Inflammatory Bowel Disease (IBD): A Case-Control Study

✍ Hazratjee, Nyla; Agito, Markus; Lopez, Rocio; Lashner, Bret; Rizk, Maged K. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Presentation and outcome of histoplasmos

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

✍ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection

The association of psoriasiform rash wit

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series

✍ Afzali, Anita; Wheat, Chelle L.; Hu, Jie Kate; Olerud, John E.; Lee, Scott D. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 804 KB

Psoriasis associated with anti-tumour ne

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

✍ G. Cullen; D. Kroshinsky; A. S. Cheifetz; J. R. Korzenik 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB